Details
Description
Inclusion Criteria
Exclusion Criteria
Details
Title A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer following First Line Platinum Based Chemotherapy.
IRB GOG 3004
CC 13-1263
Hospital Fairview, Hillcrest, Main Campus
Phase Phase 3
Disease Gynecologic
Drug Olaparib